Clinical trial NCT00794417 - References

Non-small Cell Lung Cancer — A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced Carcinoma

Citation(s)

•   Chen H, Modiano MR, Neal JW, Brahmer JR, Rigas JR, Jotte RM, Leighl NB, Riess JW, Kuo CJ, Liu L, Gao B, Dicioccio AT, Adjei AA, Wakelee HA
  A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previ
•   Diaz-Padilla I, Siu LL, San Pedro-Salcedo M, Razak AR, Colevas AD, Shepherd FA, Leighl NB, Neal JW, Thibault A, Liu L, Lisano J, Gao B, Lawson EB, Wakelee HA
  A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and c

A Phase 1/2 Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Patients With Advanced Carcinoma

Details for clinical trial NCT00794417